CervoMed Inc.
CervoMed Inc. (CRVO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRVO · as of Jun 8, 2026
Key Statistics
Explore CervoMed Inc. Data
crvo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The CRVO analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +209.28% upside from the current price of $2.91.
Competitors & Peers
crvo competitorsCRVO
ACET
ADAG
FBIO
GANX
LITSStock Performance
Full HistoryAbout CervoMed Inc.
CervoMed Inc. headquartered in Boston, Massachusetts, operates as a clinical-stage biotechnology firm committed to discovering, developing, and ultimately bringing to market pharmaceutical solutions …
what is cervomed inc. · crvo stock overview · cervomed inc. company profile · who is cervomed inc. ceo · crvo NASDAQ · cervomed inc. headquarters · cervomed inc. business segments
About Stock Overview & Key Data
CervoMed Inc. (CRVO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 23, 2008. As of the latest trading session, CRVO stock price is $2.91, with a market capitalization of $26.9M. The stock has returned -62.40% over the past 12 months and -63.16% year-to-date.
According to 7 Wall Street analysts, the consensus rating for CervoMed Inc. stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2025, CervoMed Inc. reported revenue of — and net income of -$27.0M. For detailed data — including CervoMed Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CervoMed Inc. (CRVO) stock price is $2.91. The stock is traded on NASDAQ under the ticker symbol CRVO. The 52-week range is $2.82 – $13.13.